FDA Inspection 1051599 — Oklahoma Blood Institute
The FDA completed an inspection of Oklahoma Blood Institute on April 4, 2018 in Fort Smith, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 4, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fort Smith, AR (United States)